AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Accounts payable

SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Jul 31, 20233,675+35.01%
Jul 31, 20222,722+27.85%
Jul 31, 20212,129-34.03%
Jul 31, 20203,227+3.83%
Jul 31, 20193,108+0.81%
Jul 31, 20183,083+30.25%
Jul 31, 20172,367-9.73%
Jul 31, 20162,622+33.23%
Jul 31, 20151,968+1.86%
Jul 31, 20141,932

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)